LAVTX
Price
$15.03
Change
-$0.41 (-2.66%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

LAVTX vs RMFCX

Header iconLAVTX vs RMFCX Comparison
Open Charts LAVTX vs RMFCXBanner chart's image
Lord Abbett Fundamental Equity R5
Price$15.03
Change-$0.41 (-2.66%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
LAVTX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAVTX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVTX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. LAVTX (1.94B). RMFCX pays higher dividends than LAVTX: RMFCX (1.69) vs LAVTX (0.94). LAVTX was incepted earlier than RMFCX: LAVTX (9 years) vs RMFCX (23 years). LAVTX (26.00) and RMFCX (25.00) have comparable annual turnover. LAVTX has a lower initial minimum investment than RMFCX: LAVTX (0) vs RMFCX (250). LAVTX annual gain was more profitable for investors over the last year : 17.09 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. LAVTX (33.43).
LAVTXRMFCXLAVTX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD16.04911.423141%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B98.7B2%
Annual Yield % from dividends0.941.6956%
Returns for 1 year17.0912.63135%
Returns for 3 years17.7114.16125%
Returns for 5 years33.4340.3983%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc